BIVI250117C2500
- 0.15
- 0.000.00%
BioVie Newsroom
BioVie Files to Sell 7.71M Shares of Common Stock for Holders
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
BioVie | 10-Q: Q1 2025 Earnings Report
Express News | BioVie Inc - Pd-202 Trial Expected to Start Early 2025, Results by Late 2025
Express News | Biovie’s Upcoming Parkinson’s Disease Clinical Trial Is Fully Funded
(BIVI) - Analyzing BioVie's Short Interest
Express News | BioVie Inc - Prices Direct Offering of 1,146,000 Shares at $2.83 Each
BioVie Raises $6 Million in Strategic Funding
Press Release: BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement
12 Health Care Stocks Moving In Wednesday's After-Market Session
BioVie Shares Halted On Circuit Breaker To The Downside, Stock Now Down -5.95%
Investors Look Ahead to Economic Data as US Futures Decline Pre-Bell
Join BioVie's Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024
Why IRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Genprex GNPX Phase 1 Completed; BioVie BIVI Offering
BioVie Shares Surge After Pricing $6.6 Million Direct Offering, Private Placement of Warrants
Express News | BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced at-the-Market Under Nasdaq Rules
Press Release: BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Trending Stocks Today | Genprex Soars 268.03%
October 21st - US stocks trending in regular trading hours.Gainers: $Genprex(GNPX.US)$ soars 268.03% to $1.52 with a turnover of $325.21 million. $Inspire Veterinary Partners(IVP.US)$ shoots up 136.64
12 Health Care Stocks Moving In Monday's Intraday Session